+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Point-of-Care Glucose Testing Market - Global Forecast 2026-2032- Product Image
Point-of-Care Glucose Testing Market - Global Forecast 2026-2032- Product Image
New

Point-of-Care Glucose Testing Market - Global Forecast 2026-2032

  • PDF Icon

    Report

  • 193 Pages
  • January 2026
  • Region: Global
  • 360iResearch™
  • ID: 5305543
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The point-of-care glucose testing market is experiencing significant transformation as new technologies, evolving care models, and digital health integration reshape diagnostics across healthcare environments. As industry leaders navigate complex clinical and commercial challenges, successfully adapting to this dynamic ecosystem is increasingly crucial.

Market Snapshot: Point-of-Care Glucose Testing Market

The Point-of-Care Glucose Testing Market grew from USD 7.65 billion in 2025 to USD 8.14 billion in 2026, and is projected to expand further at a CAGR of 7.98%, reaching USD 13.10 billion by 2032. This growth underscores the rising demand for immediate glycemic assessment in decentralized care settings, ongoing advancements in product innovation, and expanding use in both healthcare and consumer environments. With decentralized testing becoming a priority, point-of-care glucose testing takes center stage in improving accessibility and timely clinical decisions.

Scope & Segmentation

This report delivers a comprehensive analysis of the competitive, clinical, and supply chain factors driving the point-of-care glucose testing ecosystem. Segmentation reveals critical pathways for product strategy and market positioning by senior decision-makers.

  • Product Types: Includes continuous glucose monitoring devices (intermittently scanned and real-time), traditional glucose meters, test strips, various sensor types (enzymatic and optical), and supporting software applications. These offerings allow organizations to address the full spectrum of monitoring needs, from hospital-based acute care to consumer self-monitoring.
  • End Users: Targets ambulatory surgical centers, diagnostic laboratories—both hospital-based and independent—hospitals and clinics of all sizes, and home care environments for both self-monitoring and assisted care. Stakeholder strategies must consider the unique procurement and integration requirements of each segment.
  • Distribution Channels: Covers direct sales channels, hospital pharmacies, retail pharmacies, and online platforms, such as manufacturer websites and third-party marketplaces. Each distribution model responds to different customer expectations and regional regulatory dynamics.
  • Testing Modalities: Captures invasive, minimally invasive, and non-invasive approaches, reflecting varying degrees of patient comfort and clinical application.
  • Technology Platforms: Encompasses colorimetric, electrochemical, and photometric solutions, supporting continual advancements in accuracy and device usability.
  • Portability: Differentiates between benchtop and portable systems, providing procurement teams with targeted solutions for specific care environments.
  • Regions: Addresses markets in the Americas, Europe, Middle East & Africa, and Asia-Pacific, accounting for region-specific regulatory, technology adoption, and commercial strategies. Decision-makers benefit from regionally nuanced insights into adoption patterns and supply chain opportunities.

Each area of segmentation shapes procurement, workflow integration, and go-to-market sequencing, directly influencing investment priorities and partnership models.

Key Takeaways

  • Device accuracy, integrated data capabilities, and user-friendly design now define product adoption among clinical teams and payers, influencing reimbursement and procurement outcomes.
  • Healthcare organizations increasingly prioritize actionable insights from digital health platforms, seeking beyond-the-meter intelligence for chronic disease management and patient-specific care coordination.
  • Remote monitoring and connected software applications are accelerating risk stratification and adherence, with advanced platforms enabling broader population health management initiatives.
  • Hybrid distribution approaches that blend direct, online, and retail channels are widening market presence and enabling reach into both institutional and home-based care segments.
  • Continuous investment in clinical validation, scalable manufacturing processes, and supply chain resilience remains essential to achieving meaningful differentiation and supporting sustainable market access.
  • Procurement decisions are increasingly shaped by end-to-end service offerings such as clinician training, regulatory support, and remote monitoring integration, which help drive adoption in both clinical and consumer markets.

Tariff Impact: Navigating Supply Chain Complexity

Recent tariff adjustments have intensified procurement and sourcing complexities, directly affecting component costs and strategic planning for supply chains. Manufacturers in the point-of-care glucose testing sector are diversifying suppliers, revisiting nearshoring strategies, and establishing long-term agreements to address tariff uncertainties. Healthcare providers now evaluate total cost of ownership and supplier stability, factoring in digital distribution controls and regional regulatory capabilities to support pricing consistency and adaptive access strategies in varied tariff environments.

Methodology & Data Sources

The report applies a mixed-methods approach by pairing interviews with clinical and operations stakeholders, in-depth reviews of peer-reviewed literature and regulatory publications, and extensive supply chain analysis. Findings are validated through expert panel review and practical scenario assessment for strategic relevance.

Why This Report Matters

  • Enables senior leaders to make informed investments in technology, supply chain modernization, and digital infrastructure that address care transformation and evolving payer requirements.
  • Supports executive teams in benchmarking organizational agility, optimizing go-to-market execution, and creating sustained value across multiple global regions.
  • Delivers actionable segmentation to streamline product development and guide successful market entry based on evolving clinical needs and procurement trends.

Conclusion

As healthcare delivery and reimbursement models change, leaders who proactively align technology, supply chains, and commercialization strategies will strengthen clinical adoption and achieve sustainable growth in the point-of-care glucose testing market.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Porter’s Five Forces Analysis
4.4. PESTLE Analysis
4.5. Market Outlook
4.5.1. Near-Term Market Outlook (0-2 Years)
4.5.2. Medium-Term Market Outlook (3-5 Years)
4.5.3. Long-Term Market Outlook (5-10 Years)
4.6. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025
8. Point-of-Care Glucose Testing Market, by Product Type
8.1. Continuous Glucose Monitoring Devices
8.1.1. Intermittently Scanned
8.1.2. Real Time
8.2. Glucose Meters
8.3. Sensors
8.3.1. Enzymatic
8.3.2. Optical
8.4. Software Apps
8.5. Test Strips
9. Point-of-Care Glucose Testing Market, by Test Type
9.1. Invasive
9.2. Minimally Invasive
9.3. Non Invasive
10. Point-of-Care Glucose Testing Market, by Technology
10.1. Colorimetric
10.2. Electrochemical
10.3. Photometric
11. Point-of-Care Glucose Testing Market, by Portability
11.1. Benchtop
11.2. Portable
12. Point-of-Care Glucose Testing Market, by End User
12.1. Ambulatory Surgical Centers
12.2. Diagnostic Laboratories
12.2.1. Hospital Based Labs
12.2.2. Independent Labs
12.3. Home Care
12.3.1. Assisted Home Care
12.3.2. Self Monitoring
12.4. Hospitals & Clinics
12.4.1. Large Hospitals
12.4.2. Small Clinics
13. Point-of-Care Glucose Testing Market, by Distribution Channel
13.1. Direct Sales
13.2. Hospital Pharmacies
13.3. Online Pharmacies
13.3.1. Manufacturer Websites
13.3.2. Third Party Marketplaces
13.4. Retail Pharmacies
14. Point-of-Care Glucose Testing Market, by Region
14.1. Americas
14.1.1. North America
14.1.2. Latin America
14.2. Europe, Middle East & Africa
14.2.1. Europe
14.2.2. Middle East
14.2.3. Africa
14.3. Asia-Pacific
15. Point-of-Care Glucose Testing Market, by Group
15.1. ASEAN
15.2. GCC
15.3. European Union
15.4. BRICS
15.5. G7
15.6. NATO
16. Point-of-Care Glucose Testing Market, by Country
16.1. United States
16.2. Canada
16.3. Mexico
16.4. Brazil
16.5. United Kingdom
16.6. Germany
16.7. France
16.8. Russia
16.9. Italy
16.10. Spain
16.11. China
16.12. India
16.13. Japan
16.14. Australia
16.15. South Korea
17. United States Point-of-Care Glucose Testing Market
18. China Point-of-Care Glucose Testing Market
19. Competitive Landscape
19.1. Market Concentration Analysis, 2025
19.1.1. Concentration Ratio (CR)
19.1.2. Herfindahl Hirschman Index (HHI)
19.2. Recent Developments & Impact Analysis, 2025
19.3. Product Portfolio Analysis, 2025
19.4. Benchmarking Analysis, 2025
19.5. Abbott Laboratories
19.6. AgaMatrix, Inc.
19.7. Ascensia Diabetes Care Holdings AG
19.8. B. Braun Melsungen AG
19.9. Bayer AG
19.10. Becton, Dickinson and Company
19.11. Dexcom, Inc.
19.12. EKF Diagnostics Holdings plc
19.13. F. Hoffmann-La Roche Ltd
19.14. GlySens, Inc.
19.15. HemoCue AB (Radiometer Group)
19.16. i-Health Labs, Inc.
19.17. i-SENS, Inc.
19.18. Johnson & Johnson
19.19. Medtronic plc
19.20. Nipro Corporation
19.21. Nova Biomedical Corporation
19.22. Sinocare Inc.
19.23. Trividia Health, Inc.
List of Figures
FIGURE 1. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 2. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 3. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET, FPNV POSITIONING MATRIX, 2025
FIGURE 4. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 5. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY TEST TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 6. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 7. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PORTABILITY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 9. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 11. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 13. UNITED STATES POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 14. CHINA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, 2018-2032 (USD MILLION)
List of Tables
TABLE 1. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 2. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING DEVICES, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING DEVICES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING DEVICES, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY INTERMITTENTLY SCANNED, BY REGION, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY INTERMITTENTLY SCANNED, BY GROUP, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY INTERMITTENTLY SCANNED, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY REAL TIME, BY REGION, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY REAL TIME, BY GROUP, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY REAL TIME, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY GLUCOSE METERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY GLUCOSE METERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY GLUCOSE METERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY SENSORS, BY REGION, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY SENSORS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY SENSORS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY SENSORS, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY ENZYMATIC, BY REGION, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY ENZYMATIC, BY GROUP, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY ENZYMATIC, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY OPTICAL, BY REGION, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY OPTICAL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY OPTICAL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY SOFTWARE APPS, BY REGION, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY SOFTWARE APPS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY SOFTWARE APPS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY TEST STRIPS, BY REGION, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY TEST STRIPS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY TEST STRIPS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY INVASIVE, BY REGION, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY INVASIVE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY INVASIVE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY MINIMALLY INVASIVE, BY REGION, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY MINIMALLY INVASIVE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY MINIMALLY INVASIVE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY NON INVASIVE, BY REGION, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY NON INVASIVE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY NON INVASIVE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY COLORIMETRIC, BY REGION, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY COLORIMETRIC, BY GROUP, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY COLORIMETRIC, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY ELECTROCHEMICAL, BY REGION, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY ELECTROCHEMICAL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY ELECTROCHEMICAL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PHOTOMETRIC, BY REGION, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PHOTOMETRIC, BY GROUP, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PHOTOMETRIC, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY BENCHTOP, BY REGION, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY BENCHTOP, BY GROUP, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY BENCHTOP, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PORTABLE, BY REGION, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PORTABLE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PORTABLE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 64. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 65. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 66. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2032 (USD MILLION)
TABLE 67. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY HOSPITAL BASED LABS, BY REGION, 2018-2032 (USD MILLION)
TABLE 68. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY HOSPITAL BASED LABS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 69. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY HOSPITAL BASED LABS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 70. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY INDEPENDENT LABS, BY REGION, 2018-2032 (USD MILLION)
TABLE 71. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY INDEPENDENT LABS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 72. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY INDEPENDENT LABS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 73. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY HOME CARE, BY REGION, 2018-2032 (USD MILLION)
TABLE 74. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY HOME CARE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 75. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY HOME CARE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 76. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY HOME CARE, 2018-2032 (USD MILLION)
TABLE 77. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY ASSISTED HOME CARE, BY REGION, 2018-2032 (USD MILLION)
TABLE 78. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY ASSISTED HOME CARE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 79. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY ASSISTED HOME CARE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 80. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY SELF MONITORING, BY REGION, 2018-2032 (USD MILLION)
TABLE 81. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY SELF MONITORING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 82. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY SELF MONITORING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 83. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 84. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY HOSPITALS & CLINICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 85. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY HOSPITALS & CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 86. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2032 (USD MILLION)
TABLE 87. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY LARGE HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
TABLE 88. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY LARGE HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 89. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY LARGE HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 90. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY SMALL CLINICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 91. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY SMALL CLINICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 92. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY SMALL CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 93. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 94. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2032 (USD MILLION)
TABLE 95. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY DIRECT SALES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 96. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY DIRECT SALES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 97. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 98. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY HOSPITAL PHARMACIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 99. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY HOSPITAL PHARMACIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 100. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 101. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY ONLINE PHARMACIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 102. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY ONLINE PHARMACIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 103. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY ONLINE PHARMACIES, 2018-2032 (USD MILLION)
TABLE 104. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY MANUFACTURER WEBSITES, BY REGION, 2018-2032 (USD MILLION)
TABLE 105. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY MANUFACTURER WEBSITES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 106. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY MANUFACTURER WEBSITES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 107. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY THIRD PARTY MARKETPLACES, BY REGION, 2018-2032 (USD MILLION)
TABLE 108. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY THIRD PARTY MARKETPLACES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 109. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY THIRD PARTY MARKETPLACES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 110. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 111. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY RETAIL PHARMACIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 112. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY RETAIL PHARMACIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 113. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 114. AMERICAS POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 115. AMERICAS POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 116. AMERICAS POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING DEVICES, 2018-2032 (USD MILLION)
TABLE 117. AMERICAS POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY SENSORS, 2018-2032 (USD MILLION)
TABLE 118. AMERICAS POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 119. AMERICAS POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 120. AMERICAS POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
TABLE 121. AMERICAS POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 122. AMERICAS POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2032 (USD MILLION)
TABLE 123. AMERICAS POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY HOME CARE, 2018-2032 (USD MILLION)
TABLE 124. AMERICAS POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2032 (USD MILLION)
TABLE 125. AMERICAS POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 126. AMERICAS POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY ONLINE PHARMACIES, 2018-2032 (USD MILLION)
TABLE 127. NORTH AMERICA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 128. NORTH AMERICA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 129. NORTH AMERICA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING DEVICES, 2018-2032 (USD MILLION)
TABLE 130. NORTH AMERICA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY SENSORS, 2018-2032 (USD MILLION)
TABLE 131. NORTH AMERICA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 132. NORTH AMERICA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 133. NORTH AMERICA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
TABLE 134. NORTH AMERICA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 135. NORTH AMERICA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2032 (USD MILLION)
TABLE 136. NORTH AMERICA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY HOME CARE, 2018-2032 (USD MILLION)
TABLE 137. NORTH AMERICA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2032 (USD MILLION)
TABLE 138. NORTH AMERICA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 139. NORTH AMERICA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY ONLINE PHARMACIES, 2018-2032 (USD MILLION)
TABLE 140. LATIN AMERICA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 141. LATIN AMERICA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 142. LATIN AMERICA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING DEVICES, 2018-2032 (USD MILLION)
TABLE 143. LATIN AMERICA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY SENSORS, 2018-2032 (USD MILLION)
TABLE 144. LATIN AMERICA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 145. LATIN AMERICA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 146. LATIN AMERICA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
TABLE 147. LATIN AMERICA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 148. LATIN AMERICA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2032 (USD MILLION)
TABLE 149. LATIN AMERICA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY HOME CARE, 2018-2032 (USD MILLION)
TABLE 150. LATIN AMERICA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2032 (USD MILLION)
TABLE 151. LATIN AMERICA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 152. LATIN AMERICA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY ONLINE PHARMACIES, 2018-2032 (USD MILLION)
TABLE 153. EUROPE, MIDDLE EAST & AFRICA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 154. EUROPE, MIDDLE EAST & AFRICA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 155. EUROPE, MIDDLE EAST & AFRICA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING DEVICES, 2018-2032 (USD MILLION)
TABLE 156. EUROPE, MIDDLE EAST & AFRICA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY SENSORS, 2018-2032 (USD MILLION)
TABLE 157. EUROPE, MIDDLE EAST & AFRICA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 158. EUROPE, MIDDLE EAST & AFRICA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 159. EUROPE, MIDDLE EAST & AFRICA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
TABLE 160. EUROPE, MIDDLE EAST & AFRICA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 161. EUROPE, MIDDLE EAST & AFRICA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2032 (USD MILLION)
TABLE 162. EUROPE, MIDDLE EAST & AFRICA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY HOME CARE, 2018-2032 (USD MILLION)
TABLE 163. EUROPE, MIDDLE EAST & AFRICA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2032 (USD MILLION)
TABLE 164. EUROPE, MIDDLE EAST & AFRICA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 165. EUROPE, MIDDLE EAST & AFRICA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY ONLINE PHARMACIES, 2018-2032 (USD MILLION)
TABLE 166. EUROPE POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 167. EUROPE POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 168. EUROPE POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING DEVICES, 2018-2032 (USD MILLION)
TABLE 169. EUROPE POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY SENSORS, 2018-2032 (USD MILLION)
TABLE 170. EUROPE POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 171. EUROPE POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 172. EUROPE POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
TABLE 173. EUROPE POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 174. EUROPE POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2032 (USD MILLION)
TABLE 175. EUROPE POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY HOME CARE, 2018-2032 (USD MILLION)
TABLE 176. EUROPE POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2032 (USD MILLION)
TABLE 177. EUROPE POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 178. EUROPE POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY ONLINE PHARMACIES, 2018-2032 (USD MILLION)
TABLE 179. MIDDLE EAST POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 180. MIDDLE EAST POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 181. MIDDLE EAST POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING DEVICES, 2018-2032 (USD MILLION)
TABLE 182. MIDDLE EAST POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY SENSORS, 2018-2032 (USD MILLION)
TABLE 183. MIDDLE EAST POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 184. MIDDLE EAST POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 185. MIDDLE EAST POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
TABLE 186. MIDDLE EAST POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 187. MIDDLE EAST POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2032 (USD MILLION)
TABLE 188. MIDDLE EAST POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY HOME CARE, 2018-2032 (USD MILLION)
TABLE 189. MIDDLE EAST POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2032 (USD MILLION)
TABLE 190. MIDDLE EAST POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 191. MIDDLE EAST POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY ONLINE PHARMACIES, 2018-2032 (USD MILLION)
TABLE 192. AFRICA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 193. AFRICA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 194. AFRICA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING DEVICES, 2018-2032 (USD MILLION)
TABLE 195. AFRICA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY SENSORS, 2018-2032 (USD MILLION)
TABLE 196. AFRICA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 197. AFRICA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 198. AFRICA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
TABLE 199. AFRICA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 200. AFRICA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2032 (USD MILLION)
TABLE 201. AFRICA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY HOME CARE, 2018-2032 (USD MILLION)
TABLE 202. AFRICA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2032 (USD MILLION)
TABLE 203. AFRICA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 204. AFRICA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY ONLINE PHARMACIES, 2018-2032 (USD MILLION)
TABLE 205. ASIA-PACIFIC POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 206. ASIA-PACIFIC POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 207. ASIA-PACIFIC POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING DEVICES, 2018-2032 (USD MILLION)
TABLE 208. ASIA-PACIFIC POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY SENSORS, 2018-2032 (USD MILLION)
TABLE 209. ASIA-PACIFIC POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 210. ASIA-PACIFIC POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 211. ASIA-PACIFIC POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
TABLE 212. ASIA-PACIFIC POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 213. ASIA-PACIFIC POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2032 (USD MILLION)
TABLE 214. ASIA-PACIFIC POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY HOME CARE, 2018-2032 (USD MILLION)
TABLE 215. ASIA-PACIFIC POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2032 (USD MILLION)
TABLE 216. ASIA-PACIFIC POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 217. ASIA-PACIFIC POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY ONLINE PHARMACIES, 2018-2032 (USD MILLION)
TABLE 218. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 219. ASEAN POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 220. ASEAN POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 221. ASEAN POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING DEVICES, 2018-2032 (USD MILLION)
TABLE 222. ASEAN POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY SENSORS, 2018-2032 (USD MILLION)
TABLE 223. ASEAN POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 224. ASEAN POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 225. ASEAN POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
TABLE 226. ASEAN POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 227. ASEAN POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2032 (USD MILLION)
TABLE 228. ASEAN POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY HOME CARE, 2018-2032 (USD MILLION)
TABLE 229. ASEAN POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2032 (USD MILLION)
TABLE 230. ASEAN POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 231. ASEAN POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY ONLINE PHARMACIES, 2018-2032 (USD MILLION)
TABLE 232. GCC POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 233. GCC POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 234. GCC POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING DEVICES, 2018-2032 (USD MILLION)
TABLE 235. GCC POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY SENSORS, 2018-2032 (USD MILLION)
TABLE 236. GCC POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 237. GCC POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 238. GCC POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
TABLE 239. GCC POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 240. GCC POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2032 (USD MILLION)
TABLE 241. GCC POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY HOME CARE, 2018-2032 (USD MILLION)
TABLE 242. GCC POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2032 (USD MILLION)
TABLE 243. GCC POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 244. GCC POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY ONLINE PHARMACIES, 2018-2032 (USD MILLION)
TABLE 245. EUROPEAN UNION POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 246. EUROPEAN UNION POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 247. EUROPEAN UNION POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING DEVICES, 2018-2032 (USD MILLION)
TABLE 248. EUROPEAN UNION POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY SENSORS, 2018-2032 (USD MILLION)
TABLE 249. EUROPEAN UNION POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 250. EUROPEAN UNION POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 251. EUROPEAN UNION POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
TABLE 252. EUROPEAN UNION POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 253. EUROPEAN UNION POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2032 (USD MILLION)
TABLE 254. EUROPEAN UNION POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY HOME CARE, 2018-2032 (USD MILLION)
TABLE 255. EUROPEAN UNION POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2032 (USD MILLION)
TABLE 256. EUROPEAN UNION POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 257. EUROPEAN UNION POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY ONLINE PHARMACIES, 2018-2032 (USD MILLION)
TABLE 258. BRICS POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 259. BRICS POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 260. BRICS POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING DEVICES, 2018-2032 (USD MILLION)
TABLE 261. BRICS POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY SENSORS, 2018-2032 (USD MILLION)
TABLE 262. BRICS POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 263. BRICS POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 264. BRICS POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
TABLE 265. BRICS POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 266. BRICS POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2032 (USD MILLION)
TABLE 267. BRICS POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY HOME CARE, 2018-2032 (USD MILLION)
TABLE 268. BRICS POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2032 (USD MILLION)
TABLE 269. BRICS POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 270. BRICS POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY ONLINE PHARMACIES, 2018-2032 (USD MILLION)
TABLE 271. G7 POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 272. G7 POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 273. G7 POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING DEVICES, 2018-2032 (USD MILLION)
TABLE 274. G7 POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY SENSORS, 2018-2032 (USD MILLION)
TABLE 275. G7 POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 276. G7 POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 277. G7 POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
TABLE 278. G7 POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 279. G7 POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2032 (USD MILLION)
TABLE 280. G7 POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY HOME CARE, 2018-2032 (USD MILLION)
TABLE 281. G7 POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2032 (USD MILLION)
TABLE 282. G7 POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 283. G7 POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY ONLINE PHARMACIES, 2018-2032 (USD MILLION)
TABLE 284. NATO POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 285. NATO POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 286. NATO POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING DEVICES, 2018-2032 (USD MILLION)
TABLE 287. NATO POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY SENSORS, 2018-2032 (USD MILLION)
TABLE 288. NATO POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 289. NATO POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 290. NATO POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
TABLE 291. NATO POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 292. NATO POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2032 (USD MILLION)
TABLE 293. NATO POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY HOME CARE, 2018-2032 (USD MILLION)
TABLE 294. NATO POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2032 (USD MILLION)
TABLE 295. NATO POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 296. NATO POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY ONLINE PHARMACIES, 2018-2032 (USD MILLION)
TABLE 297. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 298. UNITED STATES POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, 2018-2032 (USD MILLION)
TABL

Companies Mentioned

The key companies profiled in this Point-of-Care Glucose Testing market report include:
  • Abbott Laboratories
  • AgaMatrix, Inc.
  • Ascensia Diabetes Care Holdings AG
  • B. Braun Melsungen AG
  • Bayer AG
  • Becton, Dickinson and Company
  • Dexcom, Inc.
  • EKF Diagnostics Holdings plc
  • F. Hoffmann-La Roche Ltd
  • GlySens, Inc.
  • HemoCue AB (Radiometer Group)
  • i-Health Labs, Inc.
  • i-SENS, Inc.
  • Johnson & Johnson
  • Medtronic plc
  • Nipro Corporation
  • Nova Biomedical Corporation
  • Sinocare Inc.
  • Trividia Health, Inc.

Table Information

Report AttributeDetails
No. of Pages193
PublishedJanuary 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 8.14 Billion
Forecasted Market Value ( USD ) by 2032 $ 13.1 Billion
Compound Annual Growth Rate7.9%
Regions CoveredGlobal
No. of Companies Mentioned20

Related Topics

Related Reports

Point-of-Care Glucose Testing: Market Share, and Growth Analysis by Product Type (Blood Glucose Meters, Continuous Glucose Monitoring Systems), Application, End User, Technology - Product Image

Point-of-Care Glucose Testing: Market Share, and Growth Analysis by Product Type (Blood Glucose Meters, Continuous Glucose Monitoring Systems), Application, End User, Technology

  • Report
  • 150 Pages
  • Global
From
Point-of-Care Glucose Testing Market - Global Strategic Business Report - Product Image

Point-of-Care Glucose Testing Market - Global Strategic Business Report

  • Report
  • 201 Pages
  • Global
From
Point-of-Care Glucose Testing Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031 - Product Image

Point-of-Care Glucose Testing Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031

  • Report
  • 185 Pages
  • Global
From
Point-of-Care Glucose Testing Market Report 2025 - Product Image

Point-of-Care Glucose Testing Market Report 2025

  • Report
  • 200 Pages
  • Global
From
2025 Global Forecast for Network Point-Of-Care Glucose Testing Market (2026-2031): High Tech Outlook Report - Product Image

2025 Global Forecast for Network Point-Of-Care Glucose Testing Market (2026-2031): High Tech Outlook Report

  • Report
  • 132 Pages
  • Global
From

About the Point of Care Glucose Testing Market

Point of Care Glucose Testing (POCT) is a type of glucose testing that is performed outside of a laboratory setting. It is typically used to monitor glucose levels in patients with diabetes, and is often used in emergency situations. POCT is a convenient and cost-effective way to measure glucose levels, as it does not require a laboratory or specialized equipment. The results are usually available within minutes, allowing for quick and accurate diagnosis and treatment. POCT is also used to monitor glucose levels in pregnant women, as well as to diagnose and monitor other conditions such as hypoglycemia. The POCT market is growing rapidly, driven by the increasing prevalence of diabetes and other chronic conditions, as well as the need for rapid and accurate diagnosis and treatment. The market is also being driven by technological advancements, such as the development of portable and user-friendly devices. Some companies in the POCT market include Abbott, Roche, Siemens, and LifeScan. Show Less Read more

Copyright © 2002-2026 Research and Markets. All Rights Reserved.